Literature DB >> 24718794

Photoswitching of cell surface receptors using tethered ligands.

Andreas Reiner1, Ehud Y Isacoff.   

Abstract

Optical probing and manipulation of cellular signaling has revolutionized biological studies ranging from isolated cells to intact tissues in the live animal. A promising avenue of optical manipulation is Chemical Optogenetics (or Optogenetic Pharmacology), an approach for engineering specific proteins to be rapidly and reversibly switched on and off with light. The approach employs synthetic photoswitched ligands, which can be reversibly photo-isomerized to toggle back and forth between two conformations in response to two wavelengths of light. We focus here on the photoswitched tethered ligand (PTL) approach in which the PTL is covalently attached in a site-directed manner to a signaling protein. For this a ligand anchoring site is introduced at a location which allows the ligand to dock only in one of the light-controlled conformations, thus enabling liganding to be rapidly switched. The ligand can be an agonist, antagonist or an active site (or pore) blocker. In principle, orthogonal chemistries of attachment would make PTL anchoring completely unique. However, extremely high specificity of remote control is also obtained by cysteine attachment because of the ligand specificity and precise geometric requirements for liganding. We describe here the design of light-gated ionotropic and metabotropic glutamate receptors, the selection of a site for cysteine placement, the method for PTL attachment, and a detailed protocol of photoswitching experiments in cultured cells. These descriptions can guide applications of Chemical Optogenetics to other receptors and serve as a starting point for use in more complex preparations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24718794     DOI: 10.1007/978-1-4939-0470-9_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Synapses in the spotlight with synthetic optogenetics.

Authors:  Shai Berlin; Ehud Y Isacoff
Journal:  EMBO Rep       Date:  2017-04-10       Impact factor: 8.807

Review 2.  Controlling ionotropic and metabotropic glutamate receptors with light: principles and potential.

Authors:  Andreas Reiner; Joshua Levitz; Ehud Y Isacoff
Journal:  Curr Opin Pharmacol       Date:  2015-01-05       Impact factor: 5.547

3.  Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells.

Authors:  Benjamin M Gaub; Michael H Berry; Amy E Holt; Andreas Reiner; Michael A Kienzler; Natalia Dolgova; Sergei Nikonov; Gustavo D Aguirre; William A Beltran; John G Flannery; Ehud Y Isacoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

4.  Holographic two-photon activation for synthetic optogenetics.

Authors:  Ido Carmi; Marco De Battista; Laura Maddalena; Elizabeth C Carroll; Michael A Kienzler; Shai Berlin
Journal:  Nat Protoc       Date:  2019-02-25       Impact factor: 13.491

5.  A Toolkit for Orthogonal and in vivo Optical Manipulation of Ionotropic Glutamate Receptors.

Authors:  Joshua Levitz; Andrei T Popescu; Andreas Reiner; Ehud Y Isacoff
Journal:  Front Mol Neurosci       Date:  2016-02-02       Impact factor: 5.639

Review 6.  Genetic Code Expansion and Optoproteomics.

Authors:  Yuting Chen; Linjie Lu; Shixin Ye
Journal:  Yale J Biol Med       Date:  2017-12-19

7.  Azologization of serotonin 5-HT3 receptor antagonists.

Authors:  Karin Rustler; Galyna Maleeva; Piotr Bregestovski; Burkhard König
Journal:  Beilstein J Org Chem       Date:  2019-03-25       Impact factor: 2.883

Review 8.  Electrophysiology Read-Out Tools for Brain-on-Chip Biotechnology.

Authors:  Csaba Forro; Davide Caron; Gian Nicola Angotzi; Vincenzo Gallo; Luca Berdondini; Francesca Santoro; Gemma Palazzolo; Gabriella Panuccio
Journal:  Micromachines (Basel)       Date:  2021-01-24       Impact factor: 2.891

Review 9.  Synthetic biology for pharmaceutical drug discovery.

Authors:  Jean-Yves Trosset; Pablo Carbonell
Journal:  Drug Des Devel Ther       Date:  2015-12-03       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.